FIELD: medicine; oncology.
SUBSTANCE: method is based on introduction in patient's organism of cytostatic preparation with mechanism of action based on interchain cross-linking within DNA molecule of cancer cells with preparation of fragmented allogen DNA with the fragments of biologically active dimension and composing entire gene of physiologically and genetically healthy donor.
EFFECT: method enables to activate recombination cell system and to provide homologous integration of DNA preparation into recipient gene.
3 cl, 5 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING DISEASES | 2006 |
|
RU2322264C1 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2006 |
|
RU2313349C2 |
ONCOTHERAPY | 2008 |
|
RU2387456C1 |
METHOD OF DETECTING STEM CANCER CELLS | 2013 |
|
RU2530170C1 |
METHOD OF TREATING CANCER | 2009 |
|
RU2429019C2 |
METHOD FOR ERADICATION OF INITIATING CANCER STEM CELLS | 2013 |
|
RU2542410C1 |
METHOD OF OBTAINING STIMULATED DENDRITE CELLS FOR INDUCTION OF IMMUNE RESPONSE AGAINST HUMAN TUBERCULOSIS | 2009 |
|
RU2401664C1 |
METHOD OF TREATING ASCITIC CARCINOMA | 2015 |
|
RU2595864C1 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2017 |
|
RU2662354C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2012 |
|
RU2490028C1 |
Authors
Dates
2009-02-10—Published
2007-04-03—Filed